Navigation Links
Single J Urinary Diversion Specialty Stent Kit - Silitek

ProductsSingle J Urinary Diversion Specialty Stent Kit - Silitek
Company GYRUS ACMI
Item Single J Urinary Diversion Specialty Stent Kit - Silitek
Features 
  • Available in proven, time-tested silicone > Enhances patient comfort and reduces stent encrustation
  • Available in advanced, biocompatible Silitek > Combines flexibility with rigidity for comfort and control
  • Medial line and incremental markings > Aid in proper placement.
Description Whether you prefer silicone or Silitek, ACMI Single J Urinary Diversion Specialty Stents help promote healing after surgery. Following cystectomy, the Single J guards against anastomotic stricture, supports the ileal intestinal anastomosis, and assists in the prevention of postoperative leakage. Following ureteroscopy, the Single J helps prevent ureteral strictures, promotes rapid healing, and may be removed without cystoscopy. Each Silicone Single-J Urinary Diversion Specialty Stent Kit contains two urinary diversion stents and one .028" x 100 cm PTFE-coated guidewire.
Info GYRUS ACMI
Customer Service: (508) 804-2600
Web site: http://www.acmicorp.com

Related medicine products :

1. Single Skin Hook
2. Single Tantalum Clip (50 Style)
3. Single Beam
4. Single Plate Molteno Implant (S1)
5. Pressure Ridge Single Plate Molteno Implant (D1)
6. Cottle Single Hook
7. Goldman Single Hook
8. Joseph Single Hook
9. Kleinert-Kutz Single Skin Hook
10. Ocular Single Mirror Gonio
11. Eye Vee 2.0 Single Wall Mount Rod Clear
Other Medicine News:Health News:Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast 2Health News:Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader 2Health News:Agito Networks Names New CEO, Broadens Depth of Experience of Enterprise Mobility Leader 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 2Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 3Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 4Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 5Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 6Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 7Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 8Health News:King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion 9Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 2Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 3Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 4Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 5Health News:Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections 6Health News:Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile 2Health News:Bioniche Presents MCC Data at the SIU World Uro-Oncology Update in Santiago, Chile 3